Print this page    •   Back to Web version of article

HHS Perinatal Antiretroviral Guidelines Updated

July 31, 2012

AIDSinfo announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States.

Key updates to the guidelines include:

For a complete preview of updates to the guidelines, see What's New in the Guidelines?

To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. (A separate PDF file of all tables in the guidelines can also be downloaded from the page.) To request a printed copy of the guidelines, e-mail ContactUs@aidsinfo.nih.gov.

Submit Feedback on the Perinatal ARV Guidelines

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission welcomes feedback on the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Please send your comments with the subject line "Comments on Perinatal ARV Guidelines" to ContactUs@aidsinfo.nih.gov by August 14, 2012.




This article was provided by AIDSinfo. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/64088/hhs-perinatal-antiretroviral-guidelines-updated.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.